The tumor-associated Tn antigen fosters lung metastasis and recruitment of regulatory T cells in triple negative breast cancer
- 3 December 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 32 (5) , 366-379
Abstract
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths. Among breast cancers (BC) subtypes, triple-negative (TN) BC is characterized by metastatic progression and poor patient prognosis. Although, TNBC is initially sensitive to chemotherapy, many TNBC patients rapidly develop resistance, at which point metastatic disease is highly lethal. Cancer cells present phenotypic changes or molecular signatures that distinguish them from healthy cells. The Tn antigen (GalNAc-O-Thr/Ser), which constitutes a powerful tool as tumor marker, was recently reported to contribute to tumor growth. However, its role in BC-derived metastasis has not yet been addressed. In this work, we generated a pre-clinical orthotopic Tn+ model of metastatic TNBC, which mimics the patient surgical treatment and is useful to study the role of Tn in metastasis and immunoregulation. We obtained two different cell clones, which differed in their Tn antigen expression: a high Tn-expressing and a non-expressing clone. Interestingly, the Tn-positive cell line generated significantly larger tumors and higher degree of lung metastases associated with a lower survival rate than the Tn-negative and parental cell line. Furthermore, we also found that both tumors and draining-lymph nodes from Tn+-tumor-bearing mice presented a higher frequency of CD4+ FoxP3+ T cells, while their splenocytes expressed higher levels of IL-10. In conclusion, this work suggests that the Tn antigen participates in breast tumor growth and spreading, favoring metastases to the lungs that are associated with an immunoregulatory state, suggesting that Tn-based immunotherapy could be a strategy of choice to treat these tumors.Keywords
Funding Information
- Comisión Sectorial de Investigación Científica
- Agencia Nacional de Investigación e Innovación (FCE_1_2017_1_136094)
- Ministerio de Educación y Cultura (I/FVF2017/098)
This publication has 55 references indexed in Scilit:
- The O-glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivoInternational Journal of Molecular Medicine, 2013
- Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasivenessProceedings of the National Academy of Sciences, 2013
- Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4+ T cellsJournal of Experimental Medicine, 2012
- Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processProceedings of the National Academy of Sciences, 2011
- Targeting immune suppressing myeloid-derived suppressor cells in oncologyCritical Reviews in Oncology/Hematology, 2011
- Critical Roles of Mucin 1 Glycosylation by Transactivated PolypeptideN-Acetylgalactosaminyltransferase 6 in Mammary CarcinogenesisCancer Research, 2010
- Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations inCosmcCancer Research, 2008
- Absence of COSMC gene mutations in breast and colorectal carcinomasAPMIS, 2008
- Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?Breast Cancer Research and Treatment, 2006
- Monoclonal Antibody B72.3 Reacts with a Core Region Structure of O-Linked CarbohydratesTumor Biology, 1988